NASDAQ:GBNHF Greenbrook TMS (GBNHF) Stock Price, News & Analysis → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free GBNHF Stock Alerts $0.09 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.1450-Day Range$0.05▼$0.1352-Week Range$0.04▼$0.84Volume13,827 shsAverage Volume1.43 million shsMarket Capitalization$3.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial Media Get Greenbrook TMS alerts: Email Address Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report About Greenbrook TMSGreenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.Read More GBNHF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBNHF Stock News HeadlinesMay 14, 2024 | prnewswire.comGREENBROOK TMS REPORTS FIRST QUARTER OPERATIONAL AND FINANCIAL RESULTSApril 25, 2024 | prnewswire.comGREENBROOK TMS REPORTS FISCAL YEAR 2023 OPERATIONAL AND FINANCIAL RESULTSSee More Headlines Receive GBNHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:GBNHF CUSIPN/A CIK1735948 Webwww.greenbrooktms.com Phone416-322-9700FaxN/AEmployees492Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-48,910,000.00 Net Margins-72.39% Pretax Margin-73.29% Return on EquityN/A Return on Assets-73.16% Debt Debt-to-Equity RatioN/A Current Ratio0.50 Quick Ratio0.50 Sales & Book Value Annual Sales$73.79 million Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value($2.47) per share Price / Book-0.04Miscellaneous Outstanding Shares40,800,000Free Float31,959,000Market Cap$3.71 million OptionableN/A Beta1.88 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Sasha Cucuz (Age 45)Executive Chairman Mr. William P. Leonard (Age 59)President, CEO & Director Comp: $468.75kDr. Geoffrey Garland Grammer M.D. (Age 52)Chief Medical Officer Comp: $293.75kMr. Peter WillettChief Financial OfficerMr. Andrew CrishChief Operating OfficerGlen AkselrodInvestor Relations OfficerMs. Iris KrugVP of Compliance & Privacy OfficerMs. Brittany SchwemmerVice President of Human ResourcesMore ExecutivesKey CompetitorsMangoceuticalsNASDAQ:MGRXBioRestorative TherapiesNASDAQ:BRTXOntrakNASDAQ:OTRKNexImmuneNASDAQ:NEXIBright Minds BiosciencesNASDAQ:DRUGView All Competitors GBNHF Stock Analysis - Frequently Asked Questions How have GBNHF shares performed in 2024? Greenbrook TMS's stock was trading at $0.0630 at the beginning of 2024. Since then, GBNHF stock has increased by 44.6% and is now trading at $0.0911. View the best growth stocks for 2024 here. How were Greenbrook TMS's earnings last quarter? Greenbrook TMS Inc. (NASDAQ:GBNHF) announced its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.32) earnings per share for the quarter. The firm had revenue of $18.01 million for the quarter. What ETF holds Greenbrook TMS's stock? AdvisorShares Psychedelics ETF holds 1,109,763 shares of GBNHF stock, representing 1.47% of its portfolio. How do I buy shares of Greenbrook TMS? Shares of GBNHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GBNHF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Former CIA advisor: Dark side of AI now startingParadigm PressNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenbrook TMS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.